Image

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Studying 18F PET's effect on prostate cancer after unclear PSMA results.

Recruiting
18 years and older
Male
Phase 4
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at using a special scan called Fluciclovine (18F) PET to help manage prostate cancer when another scan, PSMA PET, doesn't give clear results. Prostate cancer can come back after treatment, which is called biochemical recurrence (BCR). The Fluciclovine PET scan uses a radioactive substance to help doctors see cancer better.

Key Points:

  • The study involves several visits to get the Fluciclovine PET scan after a PSMA PET scan shows unclear results.
  • Participants must be men over 18, with signs of prostate cancer returning, and agree to use contraception for 24 hours after the scan.
  • Participants should not have certain health conditions or be involved in other clinical trials.
Print
Study details
    Prostate Cancer

NCT07569926

Blue Earth Diagnostics

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.